Stroke patients' knowledge about cardiovascular family history - the Norwegian Stroke in the Young Study (NOR-SYS)

Halvor Øygarden1,2, Annette Fromm3,4, Kristin Modalsli Sand5

  • 1Department of Clinical Medicine, University of Bergen, Bergen, Norway. havy@helse-bergen.no.

BMC Neurology
|April 18, 2015
PubMed

Insights

Family history (FH) significantly impacts cardiovascular disease risk. This study found young and middle-aged stroke patients have substantial cardiovascular FH, with women reporting more knowledge than men.

Area of Science:

  • Neurology
  • Cardiology
  • Genetics

Background:

  • Family history (FH) is a known risk factor for cardiovascular disease (CVD), including coronary artery disease (CAD), but its association with stroke risk is less understood.
  • This study focuses on young and middle-aged ischemic stroke patients, investigating their awareness of family history for stroke, CAD, and peripheral artery disease (PAD).
  • A particular emphasis is placed on identifying potential sex differences in this awareness.

Purpose of the Study:

  • To assess the knowledge of young and middle-aged ischemic stroke patients regarding their family history of stroke, CAD, and PAD.
  • To explore potential sex-based differences in reporting and knowledge of cardiovascular family history.
  • To determine which cardiovascular conditions patients have the most detailed family history knowledge about.

Main Methods:

  • Prospective inclusion of ischemic stroke patients aged 15-60 years in the Norwegian Stroke in the Young Study (NOR-SYS) from September 2010 to February 2014.
  • Standardized face-to-face interviews to assess family history of stroke, CAD, and PAD in first- and second-degree relatives, including a 'don't know' option.
  • Statistical analyses included McNemar's test for paired proportions and multiple logistic regression to evaluate the influence of patient sex on FH reporting, adjusting for confounders.

Main Results:

  • Out of 257 included patients (mean age 49.5 years, 68.1% males), 59% reported a cardiovascular FH.
  • Patients reported 'don't know' for maternal grandmothers significantly less often than paternal grandmothers (32.4% vs. 45.5%, p < 0.001).
  • Female patients were more likely to report a positive cardiovascular FH (OR: 3.4; 95% CI: 1.5 to 7.7; p = 0.004) and reported 'don't know' less frequently than males. Knowledge was more detailed for CAD than for stroke in parents and siblings.

Conclusions:

  • Young and middle-aged stroke patients exhibit a considerable burden of cardiovascular family history.
  • Female patients demonstrate greater awareness and reporting of cardiovascular FH compared to male patients.
  • Knowledge regarding family history is more comprehensive for coronary artery disease than for stroke, and appears to be influenced by the sex of the relative.
Abstract

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
592
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
7.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
799
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603